A federal appeals court overturned the prior decision, ruling that Myriad Genetics could indeed hold patents to two genes that help forecast a woman's risk of breast cancer.

一家联邦上诉法院推翻了先前的裁决，裁定米利亚德基因公司确实可以拥有两种基因的专利，这两种基因可以帮助预测女性患乳腺癌的风险。